Indivior (OTC: INVVY)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.300 | ||||||
REV | 207.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Indivior (OTCPK: INVVY) through any online brokerage.
There are no as such competitors for Indivior.
The latest price target for Indivior (OTCPK: INVVY) was reported by Jefferies on Wednesday, November 21, 2018. The analyst firm set a price target for 0.00 expecting INVVY to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Indivior (OTCPK: INVVY) is $19.41 last updated June 27, 2022, 4:27 PM UTC.
There are no upcoming dividends for Indivior.
Indivior’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Indivior.
Indivior is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.